"DOI","paper_doi","paper_title_x","count_atlas_x","Publication_PMID","Publication_link","count_lnpdb_x","lnp_id","ionizable_lipid","peg_lipid","sterol_lipid","helper_lipid","lipid_molar_ratio","particle_size_nm_std","pdi_std","zeta_potential_mv_std","encapsulation_efficiency_percent_std","loading_capacity_std","target_type","nucleic_acid_sequence","peg_lipid_original","ionizable_lipid_original","helper_lipid_original","sterol_lipid_original","ionizable_lipid_smiles","peg_lipid_smiles","sterol_lipid_smiles","helper_lipid_smiles","synthesis_info","bioactivity_profile","paper_title_y","paper_authors","paper_journal","paper_year","atlas_row_id","IL_name","HL_name","CHL_name","PEG_name","atlas_ratio","ratio_order","count_atlas_y","count_lnpdb_y","lnpdb_row_ids","IL_ratio","HL_ratio","CHL_ratio","PEG_ratio","matched_id"
"10.1039/d5nr00433k","10.1039/d5nr00433k","PEGylated lipid screening, composition optimization, and structure?activity relationship determination for lipid nanoparticle-mediated mRNA delivery",25,40131321,"https://doi.org/10.1039/D5NR00433K",8,476,"OF-02","DMG-PEG2000","cholesterol","DOPE","40:1.5:28.5:30",,,"30",,"NP:fixed(molar)","mRNA","epo","DMG-PEG2k","OF-02","DOPE","cholesterol","CCCCC/C=C\C/C=C\CCCCCCC(O)CN(CC(O)CCCCCC/C=C\C/C=C\CCCCC)CCCCC1NC(=O)C(NC1=O)CCCCN(CC(O)CCCCCC/C=C\C/C=C\CCCCC)CC(O)CCCCCC/C=C\C/C=C\CCCCC","CCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO)OC(=O)CCCCCCCCCCCCC","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing; device_used: ; total_flow_rate_ml_min: ; flow_rate_ratio: ; aqueous_phase_composition: mRNA in acidic buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: ; post_processing: dialysis, ultrafiltration, diafiltration; sterilization: filtered; storage_buffer: trehalose solution (pH ~5), stored at -80°C","animal_model: female BALB/c mice (6-8 weeks); administration_route: IM; dose: 0.1 μg hEPO mRNA; gene_expression_result: ~30 ng/mL hEPO (6h post-injection, normalized to 1.0)","PEGylated lipid screening, composition optimization, and structure?activity relationship determination for lipid nanoparticle-mediated mRNA delivery","['Lingyun Liu', 'Jae-Heon Kim', 'Zhongyu Li', 'Mengwei Sun', 'Trent Northen', 'Jackie Tang', 'Emma Mcintosh', 'Shrirang Karve', 'Frank DeRosa']","Nanoscale",2025,"Row0","OF-02","DOPE","cholesterol","PEG2000","40:1.5:28.5:30","IL:PEG:CHL:HL",2,4,"['Row0' 'Row2' 'Row4' 'Row6']",40,30,28.5,1.5,"Row0"
"10.1039/d5nr00433k","10.1039/d5nr00433k","PEGylated lipid screening, composition optimization, and structure?activity relationship determination for lipid nanoparticle-mediated mRNA delivery",25,40131321,"https://doi.org/10.1039/D5NR00433K",8,477,"OF-02","DMG-PEG5k","cholesterol","DOPE","40:1.5:28.5:30","112","0.104","20","90","NP:fixed(molar)","mRNA","epo","DMG-PEG5k","OF-02","DOPE","cholesterol","CCCCC/C=C\C/C=C\CCCCCCC(O)CN(CC(O)CCCCCC/C=C\C/C=C\CCCCC)CCCCC1NC(=O)C(NC1=O)CCCCN(CC(O)CCCCCC/C=C\C/C=C\CCCCC)CC(O)CCCCCC/C=C\C/C=C\CCCCC",,"C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing; device_used: ; total_flow_rate_ml_min: ; flow_rate_ratio: ; aqueous_phase_composition: mRNA in acidic buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: ; post_processing: dialysis, ultrafiltration, diafiltration; sterilization: filtered; storage_buffer: trehalose solution (pH ~5), stored at -80°C","animal_model: female BALB/c mice (6-8 weeks); administration_route: IM; dose: 0.1 μg hEPO mRNA; gene_expression_result: ~36 ng/mL hEPO (6h post-injection, 1.2x relative)","PEGylated lipid screening, composition optimization, and structure?activity relationship determination for lipid nanoparticle-mediated mRNA delivery","['Lingyun Liu', 'Jae-Heon Kim', 'Zhongyu Li', 'Mengwei Sun', 'Trent Northen', 'Jackie Tang', 'Emma Mcintosh', 'Shrirang Karve', 'Frank DeRosa']","Nanoscale",2025,"Row1","OF-02","DOPE","cholesterol","PEG5000","40:1.5:28.5:30","IL:PEG:CHL:HL",2,4,"['Row1' 'Row3' 'Row5' 'Row7']",40,30,28.5,1.5,"Row1"
"10.1039/d5nr00433k","10.1039/d5nr00433k","PEGylated lipid screening, composition optimization, and structure?activity relationship determination for lipid nanoparticle-mediated mRNA delivery",25,40131321,"https://doi.org/10.1039/D5NR00433K",8,499,"OF-02","DMG-PEG2000","cholesterol","DOPE","40:1.5:28.5:30","~100",,,,"NP:fixed(molar)","mRNA","epo","DMG-PEG2k","OF-02","DOPE","cholesterol","CCCCC/C=C\C/C=C\CCCCCCC(O)CN(CC(O)CCCCCC/C=C\C/C=C\CCCCC)CCCCC1NC(=O)C(NC1=O)CCCCN(CC(O)CCCCCC/C=C\C/C=C\CCCCC)CC(O)CCCCCC/C=C\C/C=C\CCCCC","CCCCCCCCCCCCCC(=O)OCC(COP(=O)([O-])OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO)OC(=O)CCCCCCCCCCCCC","C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing; device_used: ; total_flow_rate_ml_min: ; flow_rate_ratio: ; aqueous_phase_composition: mRNA in acidic buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: ; post_processing: dialysis, ultrafiltration, diafiltration; sterilization: filtered; storage_buffer: trehalose solution (pH ~5), stored at -80°C","animal_model: female BALB/c mice (6-8 weeks); administration_route: IM; dose: 0.1 μg hEPO mRNA; gene_expression_result: ~30 ng/mL hEPO (benchmark, normalized to 1.0)","PEGylated lipid screening, composition optimization, and structure?activity relationship determination for lipid nanoparticle-mediated mRNA delivery","['Lingyun Liu', 'Jae-Heon Kim', 'Zhongyu Li', 'Mengwei Sun', 'Trent Northen', 'Jackie Tang', 'Emma Mcintosh', 'Shrirang Karve', 'Frank DeRosa']","Nanoscale",2025,"Row23","OF-02","DOPE","cholesterol","PEG2000","40:1.5:28.5:30","IL:PEG:CHL:HL",2,4,"['Row0' 'Row2' 'Row4' 'Row6']",40,30,28.5,1.5,"Row0"
"10.1039/d5nr00433k","10.1039/d5nr00433k","PEGylated lipid screening, composition optimization, and structure?activity relationship determination for lipid nanoparticle-mediated mRNA delivery",25,40131321,"https://doi.org/10.1039/D5NR00433K",8,500,"OF-02","DMG-PEG5k","cholesterol","DOPE","40:1.5:28.5:30","~90","~0.15","~18","~88","NP:fixed(molar)","mRNA","epo","DMG-PEG5k","OF-02","DOPE","cholesterol","CCCCC/C=C\C/C=C\CCCCCCC(O)CN(CC(O)CCCCCC/C=C\C/C=C\CCCCC)CCCCC1NC(=O)C(NC1=O)CCCCN(CC(O)CCCCCC/C=C\C/C=C\CCCCC)CC(O)CCCCCC/C=C\C/C=C\CCCCC",,"C[C@H](CCCC(C)C)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC=C4[C@@]3(CC[C@@H](C4)O)C)C","CCCCCCCC/C=C\CCCCCCCC(=O)OC[C@H](COP(=O)(O)OCCN)OC(=O)CCCCCCC/C=C\CCCCCCCC","synthesis_method: Microfluidic mixing; device_used: ; total_flow_rate_ml_min: ; flow_rate_ratio: ; aqueous_phase_composition: mRNA in acidic buffer; organic_phase_composition: Ethanol with lipids; mixing_time_sec: ; temperature_condition: ; post_processing: dialysis, ultrafiltration, diafiltration; sterilization: filtered; storage_buffer: trehalose solution (pH ~5), stored at -80°C","animal_model: female BALB/c mice (6-8 weeks); administration_route: IM; dose: 0.1 μg hEPO mRNA; gene_expression_result: ~1.2x relative to DMG-PEG2k","PEGylated lipid screening, composition optimization, and structure?activity relationship determination for lipid nanoparticle-mediated mRNA delivery","['Lingyun Liu', 'Jae-Heon Kim', 'Zhongyu Li', 'Mengwei Sun', 'Trent Northen', 'Jackie Tang', 'Emma Mcintosh', 'Shrirang Karve', 'Frank DeRosa']","Nanoscale",2025,"Row24","OF-02","DOPE","cholesterol","PEG5000","40:1.5:28.5:30","IL:PEG:CHL:HL",2,4,"['Row1' 'Row3' 'Row5' 'Row7']",40,30,28.5,1.5,"Row1"
